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Abstract
Transformation of human cells requires both SV40 large T and small t antigens. Plasmids that contained mutations in the amino-terminal
dnaJ domain of the early region fail to transform human diploid fibroblasts. However, large T dnaJ mutants can be rescued by plasmids that
express early region products other than large T antigen. The protein found to be responsible for such complementation was the third early
region product, 17KT. Similar to large T, this protein reduces levels of the retinoblastoma-related protein, p130, and stimulates cell-cycle
progression of quiescent fibroblasts, two activities of large T that are disrupted by dnaJ mutations.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Simian virus 40 (SV40) was isolated in 1960 from a
monkey kidney cell line (Sweet and Hillmon, 1960). Shortly
after isolation of the virus, it was shown to cause tumors in
rodents (Eddy et al., 1961), leading to the intense study of
the cancer-causing properties of SV40. The transforming
properties of the virus are encoded by the early region
genes, which generate three proteins, large T antigen, small
t antigen, and 17KT antigen. Large T antigen is sufficient to
transform many cell types in culture. However, small t
antigen is required for transformation in certain systems,
such as focus formation of primary human diploid fibro-
blasts (De Ronde et al., 1989; Chang et al., 1985; Porras et
al., 1996). Small t is particularly important for the transfor-
mation of quiescent cells as shown by in vitro assays (Mar-
tin et al., 1979) and in vivo studies (Choi et al., 1988; Cicala
et al., 1992). The 17KT protein has not been studied exten-
sively, although it was shown to have weak transforming
activity in rat cells (Zerrahn et al., 1993).
Recently, SV40 sequences have been detected in human
malignancies, suggesting that the virus is able to establish
infections in humans, although the mechanism of transmis-
sion in humans is unknown (reviewed by Jasani et al., 2001;
Gazdar et al., 2002). Given the potential for SV40 to be an
oncogenic human virus, it is increasingly important to un-
derstand the transforming effects of the viral early proteins
in human cells. Focus formation and anchorage-indepen-
dent growth of primary human diploid fibroblasts (HDF)
occurs with the coexpression of large T and small t antigens
(Chang et al., 1985; De Ronde et al., 1989). The functions
large T contributes to this process include the inactivation of
the retinoblastoma (RB) and p53 tumor suppressor proteins
(reviewed by Manfredi and Prives, 1994). Small t binds to
the catalytic core of protein phosphatase 2A (PP2A) and
inhibits its enzymatic activity toward most substrates (Yang
et al., 1991). The region of small t that interacts with this
enzyme is critical in small t- dependent transformation sys-
tems, including focus formation of HDF (Mungre et al.,
1994; Porras et al., 1996).
Another region required for the transformation of pri-
mary human fibroblasts is the dnaJ domain, a domain
present in all three SV40 early proteins but best studied in
large T (Porras et al., 1996). The dnaJ domain in large T
cooperates with the RB binding domain to regulate expres-
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sion of the RB family members, p130 and p107, and to
activate the E2F transcription factor (Stubdal et al., 1997;
Sheng et al., 1997; Harris et al., 1998). Moreover, the dnaJ
domain and RB binding domains in large T are required in
cis for transformation (Srinivasan et al., 1997). Double
mutations at amino acids 43 and 45, two conserved amino
acids within the dnaJ domain of the SV40 early proteins,
disrupts transformation of HDF (Porras et al., 1996). Inter-
estingly, a plasmid encoding wild-type small t antigen,
pw2t, was found to complement dnaJ mutations in large T
to promote transformation of HDF. The ability of the pw2t
plasmid to complement these mutations in large T was
intriguing because, although small t contains a functional
dnaJ domain (Srinivasan et al., 1997), it does not contain
sequences that directly regulate the activity of the RB fam-
ily of proteins.
In this study, we extended previous findings to explore
the activities that could complement dnaJ mutations in large
T antigen. Expression of small t antigen is not sufficient to
complement activities in large T that require a dnaJ domain
and an additional activity is required for transformation of
primary human fibroblasts. We identify the additional trans-
forming activity encoded by the pw2t expression plasmid as
the third SV40 early protein, 17KT antigen. 17KT comple-
ments dnaJ mutations in large T antigen to promote trans-
formation. 17KT is a regulator of the RB family member
p130 and decreases levels of p130 as efficiently as large T.
Additionally, 17KT is able to rescue a G0/G1 arrest in the
cell cycle, which likely contributes to transformation of
primary human fibroblasts.
Results
The dnaJ domain is conserved in all papovaviruses (re-
viewed by Pipas, 1992). Previous work from our laboratory
demonstrated that double mutations in the dnaJ domain
(P43L and K45N) in expression plasmids encoding large T
and small t antigen eliminated transformation of primary
human fibroblasts (Porras et al., 1996). Interestingly, these
mutations in large T (LT43/45) could be fully complemented
by a wild-type small t expression plasmid, pw2t, to promote
transformation of primary HDF. We have extended this
observation to explore the functions provided by plasmid
pw2t in complementing dnaJ domain mutations in large T.
A focus formation assay was first conducted with a
cDNA encoding wild-type small t antigen (pw2tcDNA) to
determine whether small t expression, as opposed to other
possible protein products encoded by the pw2t plasmid, is
sufficient to complement dnaJ mutations in large T antigen.
Surprisingly, although the pw2t plasmid complemented
large T dnaJ mutations to completely restore transforma-
tion, pw2tcDNA could not (Fig. 1). The failure of the cDNA
plasmid to complement dnaJ mutations was not due to
differences in small t expression between this plasmid and
the pw2t plasmid because small t levels were equivalent
(data not shown). This suggested that additional activities
other than those of small t complement the large T dnaJ
domain. The remainder of this study explored the additional
transforming ability encoded by the pw2t expression plas-
mid to understand the contribution of the dnaJ domain in the
transformation of primary human cells.
The pw2t small t expression plasmid is not a cDNA and
contains additional SV40 sequences outside the small t
coding region as shown in Fig. 2. This plasmid contains a
1.1-kb deletion that eliminates expression of large T anti-
gen, and no truncated large T proteins are expressed from
this construct (Phillips and Rundell, 1988). Subsequent to
early studies that utilized the pw2t plasmid to express wild-
type small t antigen, it was reported that SV40 encodes a
third early protein, 17KT antigen (Zerrahn et al., 1993). In
studying the pw2t sequence, it is apparent that the splice
donor site that generates the 17KT transcript, corresponding
to nucleotide 4425 in the SV40 genome, is intact in the pw2t
plasmid. However, the 17KT splice acceptor site at nucle-
otide 3679 is eliminated by the deletion downstream of the
ST coding region (dashed line in Fig. 2, ST). Since alter-
ation of preferred splice acceptor sequences can lead to the
use of alternate acceptors (reviewed by Caceres and Korn-
blihtt, 2002), it is possible that other splice acceptor sites
exist in the pw2t plasmid to generate a 17KT-like transcript.
Expression of both 17KT and small t antigen could account
for the inability of small t alone to cooperate with large T
dnaJ mutants in transformation.
To determine if transfection of HDF with pw2t leads to
expression of 17KT transcripts, RT-PCR analysis was per-
formed using the primers shown in Fig. 2. These primers are
in noncoding regions of the small t mRNA and flank the
second intron removed from 17KT transcripts. The sizes of
sequences between these two primers in authentic SV40
transcripts would be 2 kb (small t and large T transcripts)
and 1.2 kb (17KT mRNA). The pw2t plasmid contains a
1.1-kb deletion that reduces the expected size of an RT-
PCR from a small t transcript to 0.9 kb. As shown in Fig.
3A, a product of this size was found using RNA collected
from HDF cells transfected with pw2t for 2 days. In addi-
tion, a much smaller product was detected as well. Sequenc-
ing determined that this was derived from a splice between
the natural 17KT splice donor at 4425 and a cryptic down-
stream splice acceptor site at nucleotide 2601 in the SV40
early region. This acceptor site was also confirmed using a
separate primer set in RT-PCR (data not shown). The novel
splice in pw2t replaces the last four amino acids of the
17KT protein (ALLT-; Zerrahn et al., 1993) with 20 addi-
tional amino acids in-frame with the carboxy-terminus of
17KT antigen. Thus, the protein encoded by this transcript
should be similar in size to wild-type 17KT antigen.
Similar analyses done with RNAs derived from
pw2tcDNA showed that the same two RNA species were
detected with these primers (data not shown). However,
experiments with upstream primers confirmed that the large
T and 17KT splice donor at 4918 was not used. Thus,
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transcripts contain uninterrupted sequences through the
small t coding region and include natural translation stop
codons.
To determine if the novel 17KT transcript encoded by
pw2t results in expression of a protein, immunoprecipita-
tions were performed. 17KT and small t antigens have
similar molecular weights, 17 and 20 kDa, respectively.
However, 17KT was reported to be a phosphoprotein, while
small t is not phosphorylated (Zerrahn et al., 1993; Yang et
al., 1979). Therefore, to distinguish between the expression
of the two proteins, cells transfected with pw2t were labeled
with radioactive phosphate to only follow 17KT expression.
17KT cDNA was also transfected as a positive control for
immunoprecipitation. An antibody that recognizes an
epitope in the dnaJ domain of 17KT, PAb419 (Crawford et
al., 1982), was used to demonstrate that pw2t generates a
phosphorylated 17KT-like protein that comigrates with a
protein produced by 17KT cDNA (Fig. 3B). No 32P-labeled
17KT protein is detected when p2wtcDNA is used for trans-
fection.
Since pw2t encodes both small t antigen and a 17KT-like
protein, it was of interest to determine which protein coop-
erated with large T dnaJ mutations to restore transformation
of HDF. As we have shown previously (Porras et al., 1996),
small t is always required for focus formation in human
cells along with wild-type large T construct and this require-
ment can be met by either pw2t or pw2tcDNA. However, as
shown in Fig. 4, transformation by large T with mutations in
the dnaJ domain required not only the small tcDNA plasmid
but also the 17KT plasmid. Expression of 17KT and small
t restored transformation with a somewhat reduced effi-
ciency compared to transformation observed with pw2t.
This may reflect the need for three plasmids to be efficiently
cotransfected for transformation to occur.
The requirement for 17KT to cooperate in transformation
when large T antigen is mutated in the dnaJ domain sug-
gested that it provides important growth promoting func-
tions which are not provided by small t. 17KT contains a
putative RB binding domain in addition to a dnaJ domain.
These two domains are sufficient in large T antigen to
inhibit the activity of RB family members and to activate
E2F. Mutations in the dnaJ domain of large T disrupt reg-
ulation of the RB-related proteins p130 and p107 (Stubdal et
al., 1997). RB, p130, and p107 inhibit cell-cycle progres-
sion by inactivating the E2F family of transcription factors
(Bagchi et al., 1991; Chellappan et al., 1991; Cao et al.,
1992; Shirodkar et al., 1992; Cobrinik et al., 1993). This
suggested that 17KT might also promote transformation by
regulating RB family members, an activity that large T dnaJ
mutants and small t cannot provide. Consistent with this
hypothesis, 17KT plasmids with mutations in the RB bind-
ing region were unable to complement small t and the dnaJ
mutants of large T in transformation (data not shown).
Based on previous data that the first 136 amino acids of
large T antigen were sufficient to bind the RB family of
proteins in insect cells (Srinivasan et al., 1997), we expected
that 17KT could also interact with these proteins because it
is identical to large T in the first 131 amino acids. We first
determined whether the RB binding motif of 17KT is func-
tional by performing coimmunoprecipitation experiments
with the RB family member p130. Large T or 17KT were
expressed in HDF and immunoprecipitated with PAb419.
Fig. 1. Small t is not sufficient to complement dnaJ mutations in large T
antigen. Primary HDF were transfected with 2 g of plasmids encoding
either wild-type or the dnaJ mutant of large T (LT43/45), in combination
with 2 g of pw2t or small t cDNA (pw2tcDNA). Cells were maintained in
DME 1% FBS for 4 weeks at which time cells were fixed with methanol
and foci were visualized with 0.4% methylene blue.
Fig. 2. Diagram of SV40 early transcripts. The three transcripts that encode
small t, large T, and 17KT antigens are shown, including the nucleotide
positions of the splice donor and splice acceptor sequences. The coding
region is shaded and noncoding sequences are shown in white. The 1.1-kb
deletion in the pw2t plasmid is marked by a dashed box. Primers used in
RT-PCR in Fig. 3 are shown by arrows.
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p130 associated with 17KT was detected following Western
blotting of immunoprecipitates and is shown in Fig. 5.
A role for 17KT in driving p130 turnover was also
suggested by findings that pw2t, but not pw2tcDNA, could
alter p130 profiles following transfection (Fig. 6A). This
and the coimmunoprecipitation experiments just described
suggested that 17KT would reduce levels of p130, similar to
the activity reported for large T antigen (Stubdal et al.,
1997). To address whether 17KT could also provide this
function, p130 levels were followed in HDF expressing
17KT. Fig. 6B shows that 17KT significantly reduced levels
of slower migrating forms of p130, leading to an overall
reduction of p130 levels by 60%. We confirmed that the
higher molecular weight forms of p130 were due to phos-
phorylation by pretreating extracts with -phosphatase prior
to SDS–PAGE (data not shown). Since reduction of p130
levels by large T antigen requires an intact dnaJ domain
(Fig. 6A and Stubdal et al., 1997), double mutations P43L
and K45N in the dnaJ domain were introduced into a 17KT
cDNA to test if this region of 17KT is required to regulate
p130 levels. As shown in Fig. 6C, a functional dnaJ domain
in 17KT antigen is required to reduce levels of p130 in
human fibroblasts. The inability of the 17KT dnaJ mutant to
regulate p130 levels was not due to instability of the protein,
as steady-state levels of the mutant 17KT protein were
comparable to wild-type 17KT antigen (Fig. 6D).
RB binding and p130 inactivation by large T is sufficient
to promote proliferation of rodent cells (Sompayrac and
Danna, 1994; Stubdal et al., 1997; Tevethia et al., 1997).
Human cells differ in this regard in that inactivation of the
RB family of proteins by large T is not sufficient to drive
cell-cycle progression of density-arrested human fibro-
blasts. In contrast to rodent cells, both large T and small t
antigen are required to promote proliferation of arrested
HDF (Porras et al., 1999). Accordingly, we tested if 17KT
could stimulate cell-cycle progression of HDF expressing
small t antigen. When large T dnaJ mutants were expressed
in HDF that expressed small t antigen, a majority of cells
Fig. 3. Plasmid pw2t encodes 17KT transcripts and protein. (A) RT-PCR analysis of total RNA from cells transfected with plasmid pw2t. HDF were
transfected with 5 g of pw2t and total RNA was collected 2 days after transfection. RT-PCR was performed with 1 g of RNA in the presence () or
absence () of AMV reverse transcriptase (RT). One- fifth of each reaction was resolved on a 1% agarose gel with a 1-kb ladder (Promega). (B) 293 cells
were transfected with empty vector, pw2t, pw2tcDNA, or plasmid encoding 17KT. Two days after transfection, cells were labeled with 100 Ci/mL [32P]
phosphate overnight in phosphate-free media. Extracts were immunoprecipitated with PAb419 and separated on a 20% Tris–sulfate gel. Bands corresponding
to 17KT were visualized by autoradiography.
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(55%) remained in the G0/G1 phase of the cell cycle, similar
to cells transfected with a vector control (Fig. 7A). Inter-
estingly, expression of 17KT along with the large T mutant
stimulated cell-cycle progression, indicated by the reduction
of cells in G1 phase (36%). It seems likely that this is not
actual complementation because, as shown in Fig. 7B,
17KT can drive cells from G1 to S even in the absence of
large T. Neither large T nor 17KT can exert this effect in
primary HDF cells that lack small t (data not shown).
The effect of 17KT on p130 turnover and S phase pro-
gression in the presence of small t antigen suggested that
17KT should affect E2F-mediated transcription. To test this
possibility, cells were cotransfected with pE2F-LUC, a plas-
mid that contains three copies of an E2F consensus se-
quence, along with the 17KT expression plasmid. As shown
in Fig. 7C, 17KT efficiency activates transcription of the
luciferase reporter gene.
To understand the role of 17KT in the context of viral
infections, we wished to generate a SV40 virus deficient in
17KT. Because earlier studies of 17KT focused on its ex-
Fig. 6. p130 levels are reduced in cells expressing 17KT antigen. (A) HDF
were transfected with plasmids encoding large T (LT), a large T dnaJ
mutant (LT43/45), small t (either from pw2t or from STcDNA), and a plasmid
encoding HA tagged p130. Duplicate extracts were separated on 5%
acrylamide–SDS gel and Westerns were performed with an antibody
against the HA epitope to detect p130 levels. (B) HDF were transfected
with plasmids encoding wilt-type or mutant large T (LT, LT43/45) or 17KT.
In the fourth lane, plasmids for both LT and 17KT were cotransfected. (C)
Cells were transfected with plasmids for the wild-type and dnaJ mutants of
both 17KT and large T. (D) Extracts from (C) were used for Western
blotting with PAb419 to show that levels of wild-type and mutant 17KT
and large T were comparable.
Fig. 4. 17KT antigen complements large T dnaJ mutations in transforma-
tion. HDF were transfected with 2 g of the plasmids described in Fig. 1,
with the addition of 2 g of either a vector control, or a plasmid encoding
17KT cDNA. Focus assays were performed as described in Fig. 1.
Fig. 5. Coimmunoprecipitation of p130 with large T and 17KT antigens.
HDF were transfected with 5 g of cDNAs encoding 17KT or large T with
1 g of either a vector control or with a plasmid encoding HA-p130.
Extracts were collected 2 days after transfection and were immunoprecipi-
tated with PAb419. Immunoprecipitates were separated on a 9% acrylam-
ide–SDS gel, transferred to PVDF membranes, and probed with an anti-
body to the HA epitope (Covance) or with PAb419. Bands corresponding
to large T and 17KT from the same blot were placed side by side for easier
viewing.
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pression in nonpermissive infections (Zerrahn et al., 1993),
we first determined the levels of 17KT in permissive infec-
tions. CV-1 cells were infected with wild-type SV40 (wt) or
mock-infected and 17KT expression in cells was monitored
by immunoprecipitation and detection of phosphorylated
protein. Fig. 8A shows that 17KT expression is maximal by
32 h after infection and this temporal expression is consis-
tent with other proteins encoded by the early region of the
viral genome (Fig. 8B) (Yang et al., 1979).
In an effort to eliminate 17KT expression in SV40,
mutations were constructed in the splice donor site at nu-
cleotide 4425 in the viral genome. Three mutations were
generated in SV40 and are shown in Table 1. Mutations
Fig. 8. Expression of early region products from wild-type (wt) and mutant
viruses. (A) Time course of 17KT expression in SV40 infected CV-1 cells.
CV-1 cells were infected with wild-type SV40 or mock infected. At 24, 32,
and 46 h postinfection, cells were labeled with 100 Ci/mL [32P] phos-
phate overnight in phosphate-free media. Extracts were immunoprecipi-
tated with PAb419 as described in Fig. 3B. (B) Time course of small t
expression. Cells were infected with SV40 and extracts were prepared at
15, 24, 35, and 48 h postinfection and small t (ST) was visualized by
Western blotting with PAb419. Only small t is shown because large T was
greatly overexposed in this film. Lighter exposures confirmed a similar
time course for large T. (C) Failure of splice donor mutations to eliminate
17KT antigen expression. CV-1 cells were mock infected or infected with
wild-type SV40 (WT), 4425, or TM viruses. Cells were labeled 30 h after
infection with 100 Ci/mL[32P]phosphate overnight in phosphate-free
media. Extracts were then immunoprecipitated with PAb419 to detect
17KT or large T antigen (LT). Two different exposures are shown because
levels of large T greatly exceed those of the 17KT.
Fig. 7. 17KT promotes cell-cycle progression and E2F-driven transcription.
(A) HDF cells that stably expressed small t (S2 cells) were transfected with
plasmids that encode large T43/45 (2 g), EGFP (1 g), and 17KT (2 g)
or a vector control (none). Cells were harvested 2 days after transfection
and were fixed in 70% ethanol and stained with 40 g/mL propidium
iodide. Samples were sorted for GFP expression and subsequently for
propidium iodide content using a Coulter cytometer (Epics XL and Modfit
software). The reduced percentage of transfected cells in G0/G1 reflects
cell-cycle progression and movement into S and G2/M. (B) S2 cells were
transfected with plasmids encoding either LT alone or 17KT alone to show
that 17KT can promote cell-cycle progression by itself. A representative
experiment is shown. (C) Cells were cotransfected with pE2F- LUC and
either a 17KT plasmid or a vector control (none). Luciferase levels were
measured in extracts prepared 2 days after transfection.
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were selected based on known consensus splice donor se-
quences (Senapathy et al., 1990), as well as mutations pre-
viously studied in JCV (Trowbridge and Frisque, 1995) and
in subgenomic derivatives of SV40 targeting this splice
donor site (Sompayrac and Danna, 1985). In addition, mu-
tations were constructed to have minimal or no alteration in
the overlapping large T coding region. The first mutant at
nucleotide 4425 does not alter the coding sequence for large
T antigen in SV40, although the triple mutant (TM) creates
a conservative amino acid change in large T at amino acid
131 (V to L). The 131–132 mutant changes the coding
sequence of large T at amino acids 131 (K to N) and 132 (V
to L).
Mutations were generated in the background of the SV40
wild-type strain 830. The viral genomes containing each
mutation were transfected into CV-1 cells to produce mu-
tant viruses that were plaque purified twice and sequenced
to confirm the presence of each mutation. Unfortunately,
analysis of the viruses containing splice donor mutations
indicated that they were not deficient in 17KT protein (Fig.
8C) or in 17KT transcripts (data not shown). The mutant
viruses showed little defect in virus growth and grew to
titers similar to wild-type SV40. Furthermore, the three
mutants were fully competent in transformation of HDF by
the SV40 early region. Thus, it was not possible to eliminate
17KT expression by targeting its splice donor in the context
of intact virus.
Discussion
The amino-terminus of large T antigen containing the
dnaJ domain is a well- characterized transformation domain
in rodent systems and is required with the RB and p53
regulatory regions in large T for transformation of these
cells (Zhu et al., 1992). Work from our laboratory previ-
ously showed that the dnaJ domain is also required in
transformation of primary human fibroblasts with large T
and small t antigens (Porras et al., 1996). Surprisingly, dnaJ
mutations in large T antigen could be fully complemented to
restore transformation of HDF by coexpression with the
pw2t plasmid. This was unexpected because the dnaJ do-
main in large T antigen works in concert with the RB-
binding domain to regulate RB family members, and al-
though small t antigen contains a functional dnaJ domain
(Srinivasan et al., 1997), it cannot regulate the RB family of
proteins directly. Our current study focused on identifying
functions that could complement dnaJ mutations in large T
antigen and demonstrated that small t expression, was not
sufficient to restore transformation, revealed by the use of a
cDNA encoding small t. The failure of small t to comple-
ment these mutations in large T led us to explore additional
transforming activities encoded by the pw2t plasmid and
revealed an important role for 17KT antigen in comple-
menting dnaJ mutations in large T.
Analysis of additional SV40 early transcripts encoded by
the pw2t plasmid demonstrated that 17KT-like transcripts
were expressed by this plasmid. Moreover, analysis of phos-
phoproteins expressed by pw2t also confirmed the presence
of a 17KT- like protein. This led us to ask whether 17KT
could complement defects in the large T dnaJ domain by
functioning as a RB regulatory protein. Other studies have
shown that dnaJ mutations in large T antigen abrogate its
ability to activate the E2F transcription factor, to promote
the turnover of p130, and to transform cells (Sheng et al.,
1997; Harris et al., 1998; Stubdal et al., 1997; Zalvide et al.,
1998). Based on the presence of both a dnaJ domain and a
RB binding domain, it seemed likely that 17KT could sub-
Table 1
Mutagenesis of 17KT splice donor site
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stitute for large T in the regulation of RB family members
to promote cell proliferation and transformation.
We demonstrated that 17KT and p130 interact in cells
and determined that expression of 17KT antigen leads to
reduction of p130 levels by more than half in quiescent
human fibroblasts. p130 levels have been monitored
throughout the cell cycle and are normally elevated in qui-
escent fibroblasts (Mayol et al., 1996; Smith et al., 1998).
This pattern of p130 expression is disrupted by 17KT anti-
gen, which decreases levels of phosphorylated p130. Simi-
lar to SV40 17KT antigen, 17KT antigen encoded by JCV
also interacts with the RB family of proteins (Bollag et al.,
2000) but the nature of the regulation of these proteins by
JCV 17KT is not fully understood.
More importantly, the reduction in levels of phosphory-
lated p130 by the 17KT protein correlated well with acti-
vation of E2F-driven transcription and the ability of 17KT
to promote cell-cycle progression, even when expressed as
the sole SV40 product. This strongly suggests that these
functions underlie the ability of 17KT to complement dnaJ
mutations in large T in transformation of human cells. These
findings are also consistent with another study demonstrat-
ing that 17KT complements a RB binding mutation in large
T antigen to restore growth of arrested rodent fibroblasts
(Gjoerup et al., 2000) and provides additional support that
17KT contains a functional RB regulatory domain.
It was surprising that we were unable to eliminate pro-
duction of 17KT protein by mutation of splice donor se-
quences in the context of the intact virus. A very similar
approach was successful in the related virus, JCV (Trow-
bridge and Frisgue, 1995), suggesting that splicing of SV40
and JCV transcripts may differ. One possible explanation is
the presence of potential GAR repeats just before the exon/
intron border. Three of these are present in SV40, but only
one is present in JCV. GAR repeats interact with S/R pro-
teins to enhance splicing (reviewed by Lopez, 1998).
Although we were unable to generate a 17KT-defective
virus for further study, it is important to recognize that there
are two ways in which SV40 can regulate the RB family of
proteins. Why might SV40 require two proteins to regulate
the same cellular proteins? Large T antigen is a multifunc-
tional protein that plays indispensable roles in viral replica-
tion and in transformation. Large T interacts with a variety
of cellular proteins (reviewed by Manfredi and Prives,
1994) and its recruitment into other multiprotein complexes
could limit its interactions with RB family members. Reg-
ulation of these by 17KT antigen could stimulate S-phase
entry of infected cells, enabling large T to associate with
other cellular proteins to initiate viral DNA replication in
lytic infection or to regulate growth inhibitory proteins,
such as p53, in a transforming infection. Thus, 17KT could
play an important role, not simply a redundant one, in the
regulation of RB family members when large T antigen is
directed into complexes with other cellular proteins.
The role of SV40 in the development of human malig-
nancies is still under investigation. SV40 sequences have
been found in many tumor types and large T antigen ex-
pression has been demonstrated in some. In a few cases, it
has also been shown that large T retains the ability to
interact with both p53 and RB tumor suppressor proteins
(Carbone et al., 1997; De Luca et al., 1997; Zhen et al.,
1999). As large T transcripts can be spliced to generate
17KT transcripts, all tumors that express large T necessarily
express 17KT antigen as well. It will continue to be impor-
tant to consider implications of the presence of both RB-
binding proteins in any tumor shown to contain and express
the SV40 early region.
Materials and methods
Cell culture
Human diploid fibroblasts were isolated from foreskins
as described (Porras et al., 1996). HDF-Tert cells (Yu et al.,
2001) were used to generate cells that expressed small t
antigen (S2 cells) by retroviral transduction with a virus
containing the small t coding region (see Plasmids). Cells
were selected for resistance to puromycin (4.5 g/mL) for 2
weeks and were pooled. Expression of small t was con-
firmed by Western blotting. Primary HDF and S2 cells were
split once a week at 1:6 and maintained in DMEM (Invitro-
gen) containing 10% FBS supplemented with L-glutamine
(Invitrogen, 20 mM), and penicillin-streptomycin (Invitro-
gen, 100 units/mL). CV-1 cells were also maintained in
media described above and were subcultured once a week at
1:20. 293 cells were maintained similarly to CV-1 cells but
were subcultured twice a week.
For focus formation assays, HDF cells were subcultured
1:4 two days after transfection and maintained for 4–6
weeks as described (Porras et al., 1996)
Transient transfections
Cells were subcultured 16–18 h prior to transfection at a
density of 4  105 cells/60 mm dish, and transfections were
performed exactly as described (Yu et al., 2001) with the
exception of CV-1 cells which were transfected as described
below.
Plasmids
Plasmids encoding wild-type and mutant large T (LT)
and/or small t antigens were described previously (Chang et
al., 1984; Porras et al., 1996). All plasmids used in trans-
formation assays contain a defective SV40 origin of repli-
cation but an intact SV40 promoter to drive gene expres-
sion.
For 17KT expression, a 17KT cDNA (from W. Deppert,
University of Hamburg) was cloned into the vector back-
ground of large T and small t constructs that contains a
chimeric intron from pCI-neo (Promega) upstream of the
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SV40 coding region. This plasmid is designated 17KT in-
tron. For large T expression, a LT cDNA was placed in the
ori-pw2T DL888 plasmid containing a chimeric intron de-
scribed above and is referred to as LT intron.
PCR mutagenesis was used to generate the P43L/K45N
mutations in 17KT. The primers used in mutagenesis were
described previously (Porras et al., 1996). A PCR fragment
containing the double mutation was digested with StuI and
PflMI and cloned into 17KT intron.
The retroviral vector containing the small t cDNA was
obtained after cloning a PCR fragment encompassing the
small t coding region into the EcoRI-SalI sites of pBabepuro
retroviral vector.
pMK is a plasmid that contains the entire wild-type
SV40 strain 830 genome (Radna et al., 1989). The viral
genome is flanked by EcoRI restriction sites and digestion
with this enzyme releases the entire genome.
A plasmid encoding HA-p130 (J. Decaprio, Dana Far-
ber) was used to generate an expression plasmid lacking the
SV40 origin of replication in pcDNA3 (Invitrogen).
Virus production and infections
The entire SV40 genome was excised by EcoRI diges-
tion from plasmid pMK. The viral genome was ligated and
transfected into CV-1 cells using a DEAE-Dextran proce-
dure (McCutchan and Pagana, 1968). Cells were observed
for cytopathic effect (CPE) to indicate virus production and
virus was collected by serial freeze-thaw when 80% cells
displayed CPE.
To titer SV40, confluent 60-mm dishes of CV-1 were
infected for 1 h and then overlayed with media containing
1% agar. Cells were fed with 1 mL DMEM after 5 days to
prevent agar from drying and plaques were visualized ap-
proximately 12–14 days after infection with 0.02% neutral
red. All viruses were plaque purified twice, and viral DNA
was sequenced after isolation with HIRT solution to confirm
various mutations (Hirt, 1967).
For SV40 infections, virus was diluted in media to obtain
a final inoculum of 0.4 mL for 60-mm dishes and 1 mL for
100-mm dishes. Virus was incubated with cells at room
temperature with occasional agitation to prevent cells from
drying. Infections were terminated with normal culture me-
dia after 1–1.5 h. For most experiments, 5 PFU/cell of SV40
was used to infect CV-1 cells unless otherwise specified in
figure legends.
Retroviruses
pBabepuro small t vector was transfected into the Phoe-
nix retroviral production cell line (Nolan Lab, Stanford
University). Approximately 5 mL of media containing ret-
rovirus was collected 2 days after transfection, filtered, and
used for infections. For retroviral infections, 1.5  105
HDF-Tert cells were plated 1 day prior to infection and
infected with 2 mL virus  10 g/l polybrene. Medium
was changed the following day and cells were placed in
selective media to obtain small t positive pools.
Western blotting
For each Western, 40 g of protein (extracted with 0.5%
Nonidet P-40 lysis buffer) was separated by SDS–PAGE
(Laemmli, 1970) gels (10% large T and 17KT, 5% for p130,
and 9% for coimmunoprecipitations). Proteins were trans-
ferred to PVDF membranes (Millipore) and membranes
were blocked in 5% milk in PBS for 60 min at room
temperature or overnight at 4°C. To detect SV40 early
protein expression, monoclonal antibody PAb419 superna-
tant (Crawford et al., 1982) was used at 1:500 for 1 h. A
monoclonal antibody against the HA epitope (Covance,
HA.11) was used to detect expressed HA-p130 at a dilution
of 1:1000 for 1 h. An anti-mouse secondary conjugated to
HRP was used at 1:2000 (Santa Cruz, SC-2005) to visualize
proteins by chemiluminescence (Pierce).
Immunoprecipitation of 17KT antigen
To detect phosphorylated 17KT antigen after transfec-
tion or infection, cells were labeled overnight with 100 Ci
of 32P-phosphate (Perkin–Elmer Life Sciences) in 2 mL of
phosphate-free DMEM. Cells were washed three times in
PBS and proteins were extracted in 400 L pH 8 extraction
buffer (20 mM Tris–Cl pH 8, 0.2% NP-40, 100 mM NaCl)
containing 1 mM sodium orthovanadate, 100 ng/L PMSF,
and 40 U/mL aprotinin. Extracts were precleared with 50
L fixed Staphylococcus aureus, Cowan strain (Harlow,
1988) for 2 h at 4°C. Cells were pelleted and the supernatant
was incubated with PAb419 for 1 h on ice. Immune com-
plexes were bound with 50 L fixed S. aureus for 30 min.
Complexes were pelleted and washed twice in 100 mM
Tris–Cl pH 8.6/500 mM LiCl and once in 20 mM Tris–Cl
pH 8.6/100 mM LiCl. Immunoprecipitates were released
from S. aureus by boiling in 1 SDS sample buffer for 5
min. Approximately 2/3 of each immunoprecipitate was
analyzed by a 20% Tris–sulfate gel (Rundell et al., 1977).
Proteins were visualized by autoradiography.
Cell-cycle analysis
Plasmids encoding either large T dnaJ mutants (LT43/45)
or 17KT cDNA were cotransfected with a plasmid encoding
green fluorescent protein (EGFPN1, Clontech). Cells were
collected by gentle trypsinization 2 days posttransfection.
Cells were fixed in 0.5% paraformaldehyde for 15 min and
permeabilized in ice-cold 70% ethanol (in PBS) for 20 min.
Cells were pelleted, washed with PBS, and resuspended in
propidium iodide (PI) stain solution containing 20 g/mL
PI (Sigma), 0.5 mg/mL RNase A (Sigma), and 10 g/mL
BSA.
FACS analysis was performed with Epics XL-MCL sys-
tem II software (Beckman Coulter) at the Robert H. Lurie
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Comprehensive Cancer Center Flow Cytometry Core Facil-
ity at Northwestern University. Transfected cells were iden-
tified based on GFP expression and DNA content was de-
termined only for transfected cells with PI with Modfit
software (Beckman Coulter).
RT-PCR of 17KT message
HDF were transfected with 5 g of pw2t and total RNA
was isolated 2 days after transfection (RNeasy, Qiagen).
RNA was treated with 1 unit of RQ1 DNase per microgram
of RNA (Promega) to remove residual DNA. For each
reaction, 1 g of RNA was used with primers PRE-RBF
(5-CCTATGGAACTGATGAATGG-3) and 2567R (5-
CCGGATCCGGACAAACCACAACTAGAATGC-3) in
SV40. Reactions were carried out using the Access RT-PCR
kit (Promega). Each amplified product was confirmed by
sequencing at the CRC sequencing facility (University of
Chicago).
Mutagenesis of 17KT splice donor site
PCR mutagenesis was performed using primers de-
scribed below that flank the splice donor sequence for 17KT
antigen. Mutated nucleotides are shown in bold. Mutations
were cloned by digesting a PCR product containing muta-
tions with NdeI, which cleaves SV40 sequences at 4826 and
3808. This fragment was cloned via the NdeI sites into pMK
plasmid and all mutations were confirmed by sequencing:
4425:
5-CCTCCAAAAAAGAAGAGAAAAGTAGAA-
GACCCC-3 and 5-GGGGTCTTCTACTTT-
TCTCTTCTTTTTTGGAGG-3.
TM:
5-CCTCCAAAAAAGAAGAGAAAACTCGAA-
GACCCC-3 and 5-GGGGTCTTCGAGTTT-
TCTCTTCTTTTTTGGAGG-3.
131–132:
5-CCTCCAAAAAAGAAGAGAAATCTCGAA-
GACCCC-3 and 5-GGGGTCTTCGAGA-
TTTCTCTTCTTTTTTGGAGG-3.
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